Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) is projected to release its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect Verrica Pharmaceuticals to post earnings of ($0.43) per share and revenue of $4.52 million for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page [...]
Verrica Pharmaceuticals (VRCA) Projected to Post Quarterly Earnings on Wednesday
